Search

Displaying results 471 - 480 of 10000 in total
  1. Drug

    Rasagiline

    go.drugbank.com/drugs/DB01367
    ApprovedInvestigational

    Rasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.

    Categories: Compounds used in a research, industrial, or household setting, Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeProducts: Ag-rasagiline, RASAGILIN AL 1 MG TAB
  2. Drug

    Ulmus americana pollen

    go.drugbank.com/drugs/DB10361
    Approved

    Ulmus americana pollen is the pollen of the Ulmus americana plant. Ulmus americana pollen is mainly used in allergenic testing.

    Products: Center-AL - Ulmus Americana Pollen
  3. Drug

    Artemisia tridentata pollen

    go.drugbank.com/drugs/DB10390
    Approved

    Artemisia tridentata pollen is the pollen of the Artemisia tridentata plant. Artemisia tridentata pollen is mainly used in allergenic testing.

    Products: Center-AL - Artemisia Tridentata Pollen
  4. Drug

    Olmesartan

    go.drugbank.com/drugs/DB00275
    ApprovedInvestigational

    [A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Like other ARBs, olmesartan blockade of RAAS slows the progression of diabetic nephropathy due to its renoprotective effects. … ARBs such as olmesartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression

    Mixtures: NORSAT-DUO, OLMEPRESS DCategories: Agents Acting on the Renin-Angiotensin System
  5. Drug

    Oxymetazoline

    go.drugbank.com/drugs/DB00935
    ApprovedInvestigational

    [L15062] As an effective decongestant, oxymetazoline is available in over-the-counter intranasal sprays used to relieve nasal and sinus congestion caused by a wide variety of conditions, such as common … [L15057] In July 2020, the FDA approved the use of an ophthalmic formulation of oxymetazoline (Upneeq) in adults with acquired blepharoptosis, or ptosis, making it the first FDA-approved medical treatment

    Categories: Sympathomimetics Used as DecongestantsProducts: Sudafed OM, Nasal D
  6. Drug

    Exenatide

    go.drugbank.com/drugs/DB01276
    ApprovedInvestigational

    Exenatide was given FDA approval on April 28, 2005[L6106]. It is available as immediate- and extended-release formulations. … [L42685,L42690] Bydureon, the brand name product of extended-release exenatide in an injectable suspension, was discontinued in 2021.

    Products: BYDUREON® BCISE® 2MG SUSPENSIÓN DE LIBERACIÓN PROLONGADA
  7. Drug

    Flunarizine

    go.drugbank.com/drugs/DB04841
    ApprovedInvestigational

    It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. … Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity.

    Products: NAFLURYL-OR
  8. Drug

    Momordica charantia fruit

    go.drugbank.com/drugs/DB14265
    Investigational

    Momordica charantia fruit is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Synonyms: Ku GuaProducts: Diabetes Out, Victory 19 Virus Out
  9. Drug

    Populus alba pollen

    go.drugbank.com/drugs/DB10383
    Approved

    Populus alba pollen is the pollen of the Populus alba plant. Populus alba pollen is mainly used in allergenic testing.

    Products: Center-AL - Populus Alba Pollen
  10. Drug

    Fagus grandifolia pollen

    go.drugbank.com/drugs/DB10350
    Approved

    Fagus grandifolia pollen is the pollen of the Fagus grandifolia plant. Fagus grandifolia pollen is mainly used in allergenic testing.

    Products: Center-AL - Fagus Grandifolia Pollen